Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Organocatalysis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105732521B reveals a metal-free TEMPO catalytic route for dihydroquinazolinone derivatives, offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN105879905B details a novel chiral phosphine catalyst enabling asymmetric RC reactions with high enantioselectivity, offering cost and supply advantages.
Patent CN104130187B details efficient asymmetric synthesis. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing supply chain.
Patent CN107759619B reveals a mild organocatalytic route for dihydropyrano-thiazoles, offering high yields and stereocontrol for reliable pharmaceutical intermediate supply chains.
Patent CN101284832A reveals a novel 9-epiquinine catalyzed route for (4S,5R)-half ester, offering high stereoselectivity and cost-effective manufacturing for Vitamin H supply chains.
Novel organocatalytic synthesis offers high stereoselectivity and yield for pharmaceutical intermediates, ensuring scalable supply chain solutions.
Patent CN102177125B reveals a robust process for alpha-hydroxy ketone production using stable alkoxyimidazolidine catalysts, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN114133349A reveals a green TBAI-catalyzed route for pyrrole derivatives, offering cost reduction and high purity for pharmaceutical intermediate manufacturing.
Novel tetrapeptide-catalyzed asymmetric Aldol synthesis for high-purity pharmaceutical intermediates. Cost-effective route to pantolactone with superior enantioselectivity.
Patent CN111848320A reveals a tetrapeptide-catalyzed asymmetric Aldol route achieving 99% ee for pantolactone precursors, offering a scalable, metal-free solution for reliable pharmaceutical intermediate suppliers.
Patent CN101157655A details a novel cinchona alkaloid-catalyzed route for (4S,5R)-half esters, offering superior yield and enantioselectivity for scalable biotin production.
Patent CN104974001A details a novel cinchona alkaloid-catalyzed route for high-purity beta-branched alpha-amino esters, offering significant supply chain and cost advantages.
Patent CN104031050A reveals high ee synthesis. Offers cost reduction and supply reliability for pharma intermediates manufacturing.
Patent CN109748841B details a metal-free organocatalytic route for chiral beta-aminoketones. This method offers high enantioselectivity and cost reduction in API manufacturing.
Discover CN101863805B technology for synthesizing chiral sulfinamide catalysts. Enables cost-effective, scalable production of high-purity pharmaceutical intermediates with superior enantioselectivity.
Patent CN113149865B reveals a metal-free mPMF catalyst for efficient ethyl α-cyanocinnamate production, offering superior selectivity and cost reduction in pharma intermediate manufacturing.
Patent CN102351777A details a novel organocatalytic route for chiral oxindoles. This report analyzes the cost-effective, metal-free synthesis for pharmaceutical intermediates.
Patent CN102127003B details a novel organocatalytic route for Tamiflu intermediates, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Novel organocatalysts for asymmetric epoxidation offering high enantioselectivity without transition metals, ensuring reliable supply chain stability.
Novel squaramide-catalyzed route for halogenated dihydropyranopyrrolones. High yield, mild conditions, antitumor activity. Ideal for API intermediates.